| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/17/2005 | CN1655770A Chewable soft capsule |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655673A Methods and compositions for treating ectoparasite infestation |
| 08/17/2005 | CN1215080C Substd. sapogenins and their use |
| 08/17/2005 | CN1215076C Heteroaromatic inhibitors of fructose 1, 6-bisphosphatase |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/17/2005 | CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 08/17/2005 | CN1214810C Oral health products for blacking hairs and pilatory effect |
| 08/17/2005 | CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/17/2005 | CN1214786C New use of modafinil and D/L enantiomer |
| 08/16/2005 | US6930220 Adhering therapeutic tool |
| 08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
| 08/16/2005 | US6930130 For use in therapy of schizophrenia, Parkinson's disease, and Alzheimer's disease |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930120 Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930115 Antitumor effect potentiators |
| 08/16/2005 | US6930114 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/16/2005 | US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 08/16/2005 | US6930096 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free cdp-choline |
| 08/16/2005 | US6930091 growth and activity promotion effects on osteoblasts |
| 08/16/2005 | US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
| 08/16/2005 | US6930088 Conformationally constrained backbone cyclized somatostatin analogs |
| 08/16/2005 | US6929950 For implanting/transfecting monodispersed silicon particles joined to DNA into target tissue, cell or the blood stream |
| 08/16/2005 | US6929818 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/16/2005 | US6929811 Active agent is selected from the group consisting of anabasine, anatabine, nomicotine, Yerbamate (Ilex paraguariensis) extract, and a liquid extract of tobacco; especially for treating psychological disorders |
| 08/16/2005 | US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein |
| 08/16/2005 | US6929797 Targeted therapeutic delivery of vitamin D compounds |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2323707C New substances derived from benzothiophenes, benzofurans and indolics, processes for preparing them and pharmaceutical compounds containing them |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2206566C Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| 08/16/2005 | CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/11/2005 | WO2005073398A1 Method of assaying capability of inhibiting fat level increase |
| 08/11/2005 | WO2005073395A1 Method of examining ability to regulate the expression of neprilysin activity |
| 08/11/2005 | WO2005073220A1 Remedy for irritable bowel syndrome with diarrhea |
| 08/11/2005 | WO2005073218A1 Therapeutic agent for vasospasm accompanying bypass operation |
| 08/11/2005 | WO2005041858A3 Mucin production inhibitor |
| 08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
| 08/11/2005 | WO2003075846A3 Uses of monoclonal antibody 8h9 |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050176993 Urokinase inhibitors, production and use thereof |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176962 Aminating a -cyanophenylalanine derivative with hydroxylamine hydrochloride in the presence of sodium carbonate in alcoholic-aqueous solution at reflux temperature to a 3-amidino derivative; chemical intermediates as highly efficient urokinase inhibitors |
| 08/11/2005 | US20050176955 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors |
| 08/11/2005 | US20050176949 E.g., (2S, 3S, 4R, 5R)-2-(5-tert-butyl-[1,3,4]oxadiazol-2-yl)-5-[6-(4-chloro-2-fluoro-phenylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol, by aminating a 6-halopurine ribofuranose nucleoside in the presence of CaCO3 and an acid; adenosine A1 receptor agonist products are also claimed |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176826 Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| 08/11/2005 | US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction |
| 08/11/2005 | US20050176824 Novel substance having antitumor/anti-inflammatory activity |
| 08/11/2005 | US20050176821 Meta-substituted phenylene sulphonamide derivatives |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176814 mono- or polydeuterated 4-(p-Methylsulfonylphenyl]-3-phenyl-2-(5H)-furanones; degenerative joint disorders, acute pain and primary dysmenorrhea |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176803 Indole derivatives as anti-inflammatory agents |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176789 Modulators of ATP-Binding Cassette transporters |
| 08/11/2005 | US20050176787 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176777 administering anabasine, anatabine, nornicotine and carriers, diluents or vehicles, for treatment drug abuse and dependence |
| 08/11/2005 | US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity |
| 08/11/2005 | US20050176764 Medicine for treating cancer |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176746 Treating eating disorders and digestive disorders wth loperamide |
| 08/11/2005 | US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's |
| 08/11/2005 | US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine |
| 08/11/2005 | US20050176737 Mitotic kinesin inhibitors |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis |
| 08/11/2005 | US20050176715 Piperidine derivatives |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |